Andy Pasternak
2021
In 2021, Andy Pasternak earned a total compensation of $6.9M as Executive Vice President, Chief Strategy Officer at Horizon Pharma, a 19% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $814,368 |
|---|---|
| Salary | $692,372 |
| Stock Awards | $5,272,731 |
| Other | $167,855 |
| Total | $6,947,326 |
Pasternak received $5.3M in stock awards, accounting for 76% of the total pay in 2021.
Pasternak also received $814.4K in non-equity incentive plan, $692.4K in salary and $167.9K in other compensation.
Rankings
In 2021, Andy Pasternak's compensation ranked 1,767th out of 12,405 executives tracked by ExecPay. In other words, Pasternak earned more than 85.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,767 out of 12,405 | 86th |
Division Manufacturing | 649 out of 5,494 | 88th |
Major group Chemicals And Allied Products | 240 out of 2,369 | 90th |
Industry group Drugs | 202 out of 2,090 | 90th |
Industry Pharmaceutical Preparations | 137 out of 1,537 | 91st |
Pay ratio
| Andy Pasternak's Pay | $6,947,326 |
|---|---|
| Median Employee's Pay | $298,200 |
| Pay Ratio | 23to 1 |
In 2021, the annual total compensation of Andy Pasternak was $6,947,326.
The annual total compensation of the median employee at Horizon Pharma was $298,200.
The ratio of Andy Pasternak's pay to the pay of median employee was therefore 23 to one.
Source: SEC filing on March 17, 2022.
Pasternak's colleagues
We found five more compensation records of executives who worked with Andy Pasternak at Horizon Pharma in 2021.